Potential to be $100 - $200 mln or $2 to $5 stock with Ovarian Cancer, Parkinson's Test, Pet Allergy Test
Ovarian Cancer OvaDx tests, PDx test for Parkinson's disease, Pet allergy test kits, Blood card kits and other things in pipeline has great potential if management can actually show progress in commercializing and capitalizing. If the management can report profits and actual deals and progress for the Dx pipeline this stock does have potential to be $5 someday. Blood Cards, Plavix Tests and thousand plus tools, technology & equipments they sell makes this a great life sciences company just wish management knew how to achieve goals and grow the company imho
I see $1 this yr for sure if not any higher - Who knows if they play their cards well this stock could jump to $10 as I have seen numerous biotechs (For example Vermillion that went from just 5 cents to $33 within 1 yr) imho.